title: Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases.
abstract: Morphologic, immunologic, cytogenetic, and clinical features were studied in 9 cases of acute undifferentiated leukemia (AUL). These patients were unclassifiable by FAB criteria, they were CD34+ and did not express myeloid- or lymphoid-associated antigens (CD13, CD33, CD14, CD15, CD61, CD19, CD10, CD22, CD7, CD2, CD5, CD3). Clonal abnormalities were seen in 8 of 9 cases. Del(5q) as the sole anomaly was observed in 3 cases; +13 was the primary change in 3 cases, and isolated trisomy 12 was found in 1 patient. A complex karyotype with trisomy 12q, in association with del 17p and trisomy 21q was detected in 1 case. One patient with 5q- relapsed with refractory anemia with excess of blasts; the presence of dysgranulopoiesis and a few blasts with possible monocytoid morphology in the remaining 2 patients point to a "myeloid nature" of these leukemias. Analysis of cytologic features in our 3 patients with +13, in combination with previously reported cases, suggests the occurrence of immature stem cell involvement with limited differentiation potential, possibly more along the myeloid than the lymphoid lineage. The significance of trisomy 12q in this subset of leukemia remains elusive; some clues of minimal differentiation towards the myeloid lineage in our cases are provided by positivity for the CD117 (c-kit) antigen and by relapse with acute myeloid leukemia without maturation (M1) in one patient. We conclude that, with presently available diagnostic techniques, AUL is a rare subset of leukemia, in which cytogenetic changes are confined to a few chromosomes, with prevalent involvement of 5q and of chromosomes 13 and 12. Chromosome findings may be of value in clinical practice, especially in those cases with "myeloid-oriented" karyotype.
authors.affiliation: Institute of Hematology, University of Ferrara, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Cuneo
authors.forename: A
authors.initials: A
authors.lastname: Ferrant
authors.forename: J L
authors.initials: JL
authors.lastname: Michaux
authors.forename: A
authors.initials: A
authors.lastname: Bosly
authors.forename: B
authors.initials: B
authors.lastname: Chatelain
authors.forename: M
authors.initials: M
authors.lastname: Stul
authors.forename: P
authors.initials: P
authors.lastname: Dal Cin
authors.forename: J
authors.initials: J
authors.lastname: Dierlamm
authors.forename: J J
authors.initials: JJ
authors.lastname: Cassiman
authors.forename: D K
authors.initials: DK
authors.lastname: Hossfeld
authors.forename: G
authors.initials: G
authors.lastname: Castoldi
authors.forename: H
authors.initials: H
authors.lastname: Van den Berghe
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D002869:Chromosome Aberrations; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D007938:Leukemia / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008875:Middle Aged; D012074:Remission Induction; D013234:Stem Cells